Sort
82,697 grants matching “vaccine development”
The functional significance of CTL escape
$699,291David I Watkins · George Washington University · R01 · FY2020 · AI
Modeling Mechanisms of Adjuvanted Influenza Vaccine Induced IgG Repertoire Diversity and Heterosubtypic Immunity
$699,202Martin S Zand · University Of Rochester · R01 · FY2019 · AI
Host Genetic Determinants of HIV Pathogenesis
$699,095Sunil K Ahuja · University Of Texas Hlth Science Center · R37 · FY2011 · AI
Mechanisms Underlying Persistent Lentivirus Replication in Follicular T Cells
$699,086Elizabeth Connick · University Of Colorado Denver · R01 · FY2013 · AI
Establishment of an H3Africa Biorepository at Contract Laboratory Services
$699,048Ute Jentsch · Wits Health Consortium (Pty), Ltd · UH3 · FY2014 · HG
Project 2
$699,043Michael S. Diamond · Washington University · U19 · FY2024 · AI
Immune diagnostics and vaccine targets: breast cancer antigens from mice to women
$699,023Mary L. Disis · University Of Washington · U01 · FY2013 · CA
Manufacturing of New Batch AV-1959D Drug Product and Placebo for Phase 1 Trial
$699,000Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2023 · AG
Bronx-Lebanon Hospital Center Pediatric ACTU
$698,974Bronx-Lebanon Hosp Ctr (Bronx, Ny) · U01 · FY2002 · AI
Development of Technologies to Facilitate the use and Response of Vaccines
$698,949Marc Joseph Gurwith · Paxvax, Inc. · N01 · FY2015 · AI
Properties of Mouse of Dendritic Cells and Macrophages
$698,921Svetlana Mojsov · Rockefeller University · R01 · FY2012 · AI
Properties of Mouse of Dendritic Cells and Macrophages
$698,921Svetlana Mojsov · Rockefeller University · R01 · FY2014 · AI
Properties of Mouse of Dendritic Cells and Macrophages
$698,921Svetlana Mojsov · Rockefeller University · R01 · FY2015 · AI
A Study of Protective Immunity Against Dengue in Infants
$698,900Daniel H. Libraty · Univ Of Massachusetts Med Sch Worcester · U01 · FY2006 · AI
Properties of Mouse of Dendritic Cells and Macrophages
$698,857Svetlana Mojsov · Rockefeller University · R01 · FY2011 · AI
ncRNA: structure, function and inhibition
$698,758Gabriele Varani · University Of Washington · R35 · FY2023 · GM
Primary Care Based Depression Prevention in Adolescents: Intervention Optimization in Preparation for Implementation Study
$698,628Benjamin W Van Voorhees · University Of Illinois At Chicago · R01 · FY2024 · MH
Immune Responses to Vibrio cholerae infection and vaccination in Haiti
$698,624Jason B Harris · Massachusetts General Hospital · R01 · FY2015 · AI
Paramyxoviruses as Vaccine Vectors Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
$698,609Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
In Vivo/In Vitro: Plac 1 Vaccine for Breast Cancer Prevention
$698,588Weill Medical Coll Of Cornell Univ · N01 · FY2012 · CA
A Systems Biology Approach to Malaria Immunity
$698,574Kim C Williamson · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2017 · AI
Molecular Approaches To Antiviral and Vaccine Development For Hepatitis C
$698,568Tsanyang Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK
Mechanisms of Effective Humoral Immune Responses to HIV-1
$698,550Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Multivalent Tick-Microbe targeted Lyme disease vaccines
$698,515Utpal Pal · Univ Of Maryland, College Park · R01 · FY2025 · AI
Human Antibodies to HIV-1 by Repertoire Cloning
$698,488Dennis R. Burton · Scripps Research Institute, The · R01 · FY2011 · AI